Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads
Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear more effectiveOzempic maker Novo Nordisk said on T...
Last updated: 2026-07-26 13:04:24 ET
Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear more effectiveOzempic maker Novo Nordisk said on T...
The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.
Novo Nordisk, the maker of Wegovy and Ozempic, has launched legal action accusing its arch rival Eli Lilly of false advertising.
The Danish company Novo says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.
Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE